BioPortfolio Biotechnology Pharmaceutical Healthcare Medical Life Science Drug Discovery Disease
Search BioPortfolio:       

«Nasopharyngeal Neoplasms

Below is an extended Nasopharyngeal Neoplasms research listing. Click here to return to the Nasopharyngeal Neoplasms main in depth entry.

Recent Publications on Nasopharyngeal Neoplasms:

p63 Expression in olfactory neuroblastoma and other small cell tumors of the sinonasal tract.
Olfactory neuroblastoma (ONB) is a rare neoplasm of the head and neck...
Direct Link
23rd August, 2008
Robert E. Fechner Surgical Pathology Laboratory, University of Virginia,
Nasopharyngectomy: does the approach to the nasopharynx influence survival?
OBJECTIVE: To investigate whether the approach used to the nasopharynx to...
Direct Link
23rd August, 2008
Department of Otorhinolaryngology, Head and Neck Surgery, The Chinese
[Nasopharyngeal angiofibroma: report of 15 cases treated by embolization]
PURPOSE: To report a series of 15 new cases of nasopharyngeal angiofibroma...
Direct Link
22nd August, 2008
HOP Charles Nicole, boulevard 9 avril, Tunis, Tunisie.
Meta-analysis of nasopharyngeal carcinoma microarray data explores mechanism of EBV-regulated neoplastic transformation.
BACKGROUND: Epstein-Barr virus (EBV) presumably plays an important role in...
Direct Link
21st August, 2008
Institute of Genetic Engineering, Southern Medical University, Guangzhou,
Follicular dendritic cell sarcoma of the nasopharynx.
Follicular dendritic cell (FDC) sarcoma is an extremely rare malignant...
Direct Link
19th August, 2008
Department of Otolaryngology and Head and Neck Surgery, "Gregorio Maranon"
Amplicons on chromosome 3 contain oncogenes induced by recurrent exposure to 12-O-tetradecanoylphorbol-13-acetate and sodium n-butyrate and Epstein-Barr virus reactivation in a nasopharyngeal carcinoma cell line.
Nasopharyngeal carcinoma (NPC) is closely associated with Epstein-Barr...
Direct Link
16th August, 2008
National Institute of Cancer Research, National Health Research
Hypericin lights up the way for the potential treatment of nasopharyngeal cancer by photodynamic therapy. 13th August, 2008
Department of Medical Sciences, National Cancer Center, Singapore,
Image analysis of DNA content and nuclear morphometry for predicting radiosensitivity of nasopharyngeal carcinoma. 1st August, 2008
Allergy and Inflammation Research Institute, Key Immunopathology
Persistent aberrations in circulating DNA integrity after radiotherapy are associated with poor prognosis in nasopharyngeal carcinoma patients.
PURPOSE: Aberrations of circulating nucleic acid integrity have been...
Direct Link
1st August, 2008
State Key Laboratory in Oncology in South China, Sir Y.K. Pao Centre for
Effect of patient-related delay in diagnosis on the extent of disease and prognosis in nasopharyngeal carcinoma.
BACKGROUND: The reasons causing the patient-related delay in diagnosis...
Direct Link
1st August, 2008
Department of Radiation Oncology, the Second Affiliated Hospital, Cancer
Nasal irrigation reduces postirradiation rhinosinusitis in patients with nasopharyngeal carcinoma.
BACKGROUND: Nasopharyngeal carcinoma (NPC) is a common head and neck...
Direct Link
1st August, 2008
Department of Otolaryngology, Taichung Veterans General Hospital,
Nasopharyngeal angiofibroma. 26th July, 2008
Department of Pathology, The George Washington University School of
A novel application of plasma and cerebrospinal fluid level of epstein barr virus DNA in the diagnosis of leptomeningeal metastasis from nasopharyngeal carcinoma. A case report.
Epstein Barr virus (EBV)-associated nasopharyngeal carcinoma (NPC) is...
Direct Link
23rd July, 2008
Department of Clinical Oncology, The Chinese University of Hong Kong,
Spontaneous T cell responses to Epstein-Barr virus-encoded BARF1 protein and derived peptides in patients with nasopharyngeal carcinoma: bases for improved immunotherapy.
Immunotherapy approaches targeting Epstein-Barr virus (EBV)-encoded...
Direct Link
19th July, 2008
Cancer Bioimmunotherapy Unit, Centro di Riferimento Oncologico,
Nasopharyngeal carcinoma with orbital involvement.
PURPOSE: To describe the clinical presentation of patients with...
Direct Link
20th June, 2008
Singapore National
 

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.  See User Agreement

Send comments and feedback to:
Peter Barfoot Managing Director, BioPortfolio Ltd.
UK Tel: (+44) 1300 321501
USA Voicemail and Fax: (+1) 415 680 2472

All rights reserved. All other trademarks recognized.

BioPortfolio Limited is registered in England & Wales at Wessex Barn, Dorchester Road, Frampton, Dorset, DT2 9NB, UK. No.3312883 VAT No. GB 744 6483 10

Copyright 1997-2008 - BioPortfolio Limited.

BioPortfolio logo

Valid XHTML 1.0 Transitional